{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:50:18Z","timestamp":1773273018135,"version":"3.50.1"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0117271","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T18:53:22Z","timestamp":1422989602000},"page":"e0117271","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of Enzyme Replacement Therapy Started Late in a Murine Model of Mucopolysaccharidosis Type I"],"prefix":"10.1371","volume":"10","author":[{"given":"Gabriela","family":"Pasqualim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talita Giacomet","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela Maria Vicente","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Matte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"ref1","first-page":"3421","article-title":"The Mucopolysaccharidoses","author":"EF Neufeld","year":"2001"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"J Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-7-22","article-title":"Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure","volume":"7","author":"MH De Ru","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"LA Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/bmt.2011.239","article-title":"Increased longevity and metabolic correction following syngeneic BMT in a murine model of mucopolysaccharidosis type I","volume":"47","author":"DA Wolf","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"J Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"MH De Ru","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment","volume":"33","author":"R Giugliani","year":"2010","journal-title":"Genet Mol Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jpeds.2009.07.005","article-title":"Guidelines for the management of mucopolysaccharidosis type I","volume":"155","author":"AM Martins","year":"2009","journal-title":"J Pediatr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years","volume":"90","author":"M Sifuentes","year":"2007","journal-title":"Mol Genet Metab"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"JE Wraith","year":"2004","journal-title":"J Pediatr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"ED Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"120","author":"JE Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00431-006-0316-8","article-title":"Enzyme replacement therapy in two patients with an advanced severe (Hurler) phenotype of mucopolysaccharidosis I","volume":"166","author":"V Tokic","year":"2007","journal-title":"Eur J Pediatr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10545-011-9436-z","article-title":"Newborn screening for lysosomal diseases: current status and potential interface with population medical genetics in Latin America","volume":"35","author":"R Giugliani","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1542\/peds.2009-1728","article-title":"Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up","volume":"125","author":"O Gabrielli","year":"2010","journal-title":"Pediatrics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"K Ohmi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbr.2012.04.051","article-title":"Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice","volume":"233","author":"G Baldo","year":"2012","journal-title":"Behav Brain Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymgme.2013.03.005","article-title":"Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice","volume":"109","author":"G Baldo","year":"2013","journal-title":"Mol Genet Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000327532","article-title":"Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells","volume":"195","author":"G Baldo","year":"2012","journal-title":"Cells Tissues Organs"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"H364","DOI":"10.1152\/ajpheart.00979.2001","article-title":"Serial noninvasive assessment of progressive pulmonary hypertension in a rat model","volume":"283","author":"JE Jones","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ymgme.2011.08.018","article-title":"Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation","volume":"104","author":"G Baldo","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymgme.2008.03.018","article-title":"Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice","volume":"94","author":"X Ma","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ymgme.2009.12.003","article-title":"Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression","volume":"99","author":"J a Metcalf","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10545-011-9336-2","article-title":"Clinical manifestations and treatment of mucopolysaccharidosis type I patients in Latin America as compared with the rest of the world","volume":"34","author":"MV Mu\u00f1oz-Rojas","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"ref26","article-title":"The natural history of MPS I: global perspectives from the MPS I Registry","author":"M Beck","year":"2014","journal-title":"Genet Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ajmg.a.32320","article-title":"Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis?","volume":"146A","author":"T Vieira","year":"2008","journal-title":"Am J Med Genet A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00431-011-1644-x","article-title":"Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry","volume":"171","author":"K D\u2019Aco","year":"2012","journal-title":"Eur J Pediatr"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10545-012-9538-2","article-title":"Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans","volume":"36","author":"MH De Ru","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymgme.2008.10.009","article-title":"A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I","volume":"96","author":"R Giugliani","year":"2009","journal-title":"Mol Genet Metab"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3109\/14653249.2012.672730","article-title":"Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-L-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice","volume":"14","author":"G Baldo","year":"2012","journal-title":"Cytotherapy"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/labinvest.2011.7","article-title":"Arterial pathology in canine mucopolysaccharidosis-I and response to therapy","volume":"91","author":"JA Lyons","year":"2011","journal-title":"Lab Invest"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/scitranslmed.3001380","article-title":"Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I","volume":"2","author":"AD Dierenfeld","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref34","first-page":"2868","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"P Dickson","year":"2008","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","article-title":"Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I","volume":"98","author":"EA Braunlin","year":"2006","journal-title":"Am J Cardiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ymgme.2011.03.016","article-title":"Laronidase replacement therapy improves myocardial function in mucopolysaccharidosis I","volume":"103","author":"H Harada","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10545-011-9444-z","article-title":"Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI","volume":"36","author":"MMMG Brands","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-9149(03)00909-3","article-title":"Usefulness of bone marrow transplantation in the Hurler syndrome","volume":"92","author":"EA Braunlin","year":"2003","journal-title":"Am J Cardiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pcl.2009.11.004","article-title":"Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders","volume":"57","author":"JJ Boelens","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.mehy.2014.01.029","article-title":"Lysosomal enzymes may cross the blood-brain-barrier by pinocytosis: Implications for Enzyme Replacement Therapy","volume":"82","author":"G Baldo","year":"2014","journal-title":"Med Hypotheses"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2013.09.008","article-title":"High-dose enzyme replacement therapy in murine Hurler syndrome","volume":"111","author":"L Ou","year":"2014","journal-title":"Mol Genet Metab"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/dds086","article-title":"Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age","volume":"21","author":"F Matthes","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity","volume":"37","author":"LD Archer","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e35787","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"FL Wilkinson","year":"2012","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2011.01.015","article-title":"Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment","volume":"103","author":"A Arfi","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"V Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainres.2007.10.036","article-title":"Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome","volume":"1188","author":"D Pan","year":"2008","journal-title":"Brain Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0117271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:18:26Z","timestamp":1540347506000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0117271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0117271","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}